Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC4
|
ENSG00000100968.9 | nuclear factor of activated T cells 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_24838154_24838623 | NFATC4 | 15 | 0.945258 | 0.82 | 6.5e-03 | Click! |
chr14_24836692_24836908 | NFATC4 | 92 | 0.926269 | 0.80 | 9.6e-03 | Click! |
chr14_24834559_24834710 | NFATC4 | 1483 | 0.203924 | 0.78 | 1.3e-02 | Click! |
chr14_24840170_24840321 | NFATC4 | 1776 | 0.175256 | 0.77 | 1.5e-02 | Click! |
chr14_24834801_24834952 | NFATC4 | 1241 | 0.247551 | 0.77 | 1.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_158113918_158114875 | 3.00 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr4_134070427_134071051 | 1.73 |
PCDH10 |
protocadherin 10 |
269 |
0.96 |
chr16_87490664_87491008 | 1.70 |
ZCCHC14 |
zinc finger, CCHC domain containing 14 |
24096 |
0.15 |
chr5_31193803_31195028 | 1.70 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr1_156541413_156541716 | 1.66 |
IQGAP3 |
IQ motif containing GTPase activating protein 3 |
768 |
0.45 |
chr3_120168709_120169860 | 1.63 |
FSTL1 |
follistatin-like 1 |
554 |
0.84 |
chr9_684288_685148 | 1.61 |
RP11-130C19.3 |
|
837 |
0.67 |
chrX_34673666_34673817 | 1.58 |
TMEM47 |
transmembrane protein 47 |
1664 |
0.56 |
chr12_960802_961189 | 1.58 |
WNK1 |
WNK lysine deficient protein kinase 1 |
136 |
0.97 |
chr10_21807539_21808360 | 1.57 |
SKIDA1 |
SKI/DACH domain containing 1 |
1101 |
0.4 |
chr2_74666737_74667617 | 1.56 |
RTKN |
rhotekin |
533 |
0.54 |
chr6_44083954_44084715 | 1.53 |
TMEM63B |
transmembrane protein 63B |
10317 |
0.15 |
chr8_93113958_93114847 | 1.49 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
1052 |
0.69 |
chr13_99714734_99715210 | 1.46 |
DOCK9 |
dedicator of cytokinesis 9 |
23688 |
0.17 |
chr13_76211856_76212147 | 1.46 |
LMO7 |
LIM domain 7 |
1542 |
0.32 |
chr3_25469138_25469713 | 1.46 |
RARB |
retinoic acid receptor, beta |
329 |
0.93 |
chr7_139899946_139900413 | 1.46 |
ENSG00000199971 |
. |
9292 |
0.16 |
chr2_9348603_9349207 | 1.45 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
2011 |
0.46 |
chr13_76212170_76212445 | 1.43 |
LMO7 |
LIM domain 7 |
1848 |
0.28 |
chr15_48935948_48936126 | 1.43 |
FBN1 |
fibrillin 1 |
1881 |
0.46 |
chr11_94473290_94474384 | 1.43 |
RP11-867G2.8 |
|
316 |
0.92 |
chr8_49447973_49448420 | 1.42 |
RP11-770E5.1 |
|
15931 |
0.3 |
chr3_29327656_29328192 | 1.41 |
RBMS3-AS3 |
RBMS3 antisense RNA 3 |
4293 |
0.26 |
chr3_99357829_99358140 | 1.41 |
COL8A1 |
collagen, type VIII, alpha 1 |
530 |
0.85 |
chr5_54456050_54456451 | 1.41 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr14_52122113_52122363 | 1.39 |
FRMD6 |
FERM domain containing 6 |
3540 |
0.25 |
chr7_41735666_41735856 | 1.39 |
INHBA-AS1 |
INHBA antisense RNA 1 |
2215 |
0.31 |
chr13_40174017_40174396 | 1.39 |
LHFP |
lipoma HMGIC fusion partner |
3102 |
0.29 |
chr4_170188672_170188986 | 1.38 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2279 |
0.41 |
chr1_150481112_150481644 | 1.37 |
ECM1 |
extracellular matrix protein 1 |
795 |
0.48 |
chr3_87036535_87037613 | 1.36 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr2_17719788_17720723 | 1.35 |
VSNL1 |
visinin-like 1 |
138 |
0.97 |
chr10_73725086_73725706 | 1.33 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
1273 |
0.55 |
chr13_32786329_32786590 | 1.32 |
FRY |
furry homolog (Drosophila) |
52346 |
0.14 |
chr12_7037386_7038830 | 1.31 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr1_170638728_170639131 | 1.31 |
PRRX1 |
paired related homeobox 1 |
5851 |
0.31 |
chr10_32201925_32202315 | 1.30 |
ARHGAP12 |
Rho GTPase activating protein 12 |
4318 |
0.31 |
chr1_218672576_218672996 | 1.30 |
C1orf143 |
chromosome 1 open reading frame 143 |
10652 |
0.26 |
chr13_76259054_76259476 | 1.30 |
LMO7 |
LIM domain 7 |
48806 |
0.13 |
chr2_189839524_189839773 | 1.29 |
COL3A1 |
collagen, type III, alpha 1 |
549 |
0.79 |
chr18_54070586_54070808 | 1.28 |
TXNL1 |
thioredoxin-like 1 |
211025 |
0.02 |
chr6_28442401_28443147 | 1.27 |
ZSCAN23 |
zinc finger and SCAN domain containing 23 |
31530 |
0.13 |
chr10_114714851_114715858 | 1.25 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr17_37856067_37857084 | 1.25 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr6_132269903_132270239 | 1.25 |
RP11-69I8.3 |
|
2015 |
0.32 |
chr13_38443609_38443896 | 1.23 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
108 |
0.98 |
chr12_51180314_51180560 | 1.23 |
ATF1 |
activating transcription factor 1 |
22145 |
0.16 |
chr13_45146263_45146555 | 1.23 |
TSC22D1 |
TSC22 domain family, member 1 |
3983 |
0.32 |
chr5_172753069_172753220 | 1.22 |
STC2 |
stanniocalcin 2 |
656 |
0.71 |
chr3_112929944_112930573 | 1.21 |
BOC |
BOC cell adhesion associated, oncogene regulated |
71 |
0.98 |
chr9_124361889_124362352 | 1.21 |
RP11-524G24.2 |
|
23627 |
0.18 |
chr4_23890359_23890765 | 1.21 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
1096 |
0.66 |
chr6_116832868_116833176 | 1.20 |
FAM26E |
family with sequence similarity 26, member E |
213 |
0.73 |
chr9_117879769_117880175 | 1.20 |
TNC |
tenascin C |
506 |
0.85 |
chr16_75298860_75299117 | 1.19 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
125 |
0.95 |
chr5_98396547_98396924 | 1.19 |
ENSG00000200351 |
. |
124284 |
0.06 |
chr7_22589223_22589977 | 1.19 |
AC002480.3 |
|
13356 |
0.2 |
chr3_159484310_159484461 | 1.19 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
1493 |
0.34 |
chr5_121412020_121412268 | 1.18 |
LOX |
lysyl oxidase |
1836 |
0.4 |
chr2_46933523_46933944 | 1.18 |
SOCS5 |
suppressor of cytokine signaling 5 |
7407 |
0.22 |
chr2_145210039_145210510 | 1.18 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
22137 |
0.25 |
chr7_27153769_27154326 | 1.18 |
HOXA-AS2 |
HOXA cluster antisense RNA 2 |
492 |
0.41 |
chr10_49812202_49812558 | 1.18 |
ARHGAP22 |
Rho GTPase activating protein 22 |
617 |
0.77 |
chr1_176866758_176867108 | 1.17 |
ENSG00000202609 |
. |
131648 |
0.06 |
chr1_179110770_179111258 | 1.17 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
1165 |
0.52 |
chr2_223916824_223917105 | 1.17 |
KCNE4 |
potassium voltage-gated channel, Isk-related family, member 4 |
102 |
0.98 |
chr8_98928953_98929409 | 1.16 |
MATN2 |
matrilin 2 |
14388 |
0.23 |
chr11_128778401_128778587 | 1.16 |
C11orf45 |
chromosome 11 open reading frame 45 |
2564 |
0.22 |
chr14_52120103_52120254 | 1.15 |
FRMD6 |
FERM domain containing 6 |
1480 |
0.42 |
chr4_164253130_164253399 | 1.14 |
NPY1R |
neuropeptide Y receptor Y1 |
484 |
0.84 |
chr5_81685080_81685386 | 1.14 |
ATP6AP1L |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
84067 |
0.1 |
chr20_30084575_30084759 | 1.14 |
HM13 |
histocompatibility (minor) 13 |
17564 |
0.11 |
chr9_36276812_36276984 | 1.12 |
GNE |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
141 |
0.96 |
chr9_91794568_91795032 | 1.12 |
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
1118 |
0.6 |
chr12_91505056_91505217 | 1.11 |
LUM |
lumican |
472 |
0.85 |
chr4_89977525_89978081 | 1.11 |
FAM13A |
family with sequence similarity 13, member A |
508 |
0.85 |
chr3_45265689_45266072 | 1.11 |
TMEM158 |
transmembrane protein 158 (gene/pseudogene) |
1890 |
0.38 |
chr3_149094469_149095370 | 1.11 |
TM4SF1-AS1 |
TM4SF1 antisense RNA 1 |
646 |
0.47 |
chr4_54063057_54063462 | 1.11 |
ENSG00000207385 |
. |
68475 |
0.13 |
chr9_21558481_21558945 | 1.11 |
MIR31HG |
MIR31 host gene (non-protein coding) |
955 |
0.56 |
chr4_153273504_153273905 | 1.10 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
419 |
0.87 |
chr19_47735595_47736220 | 1.10 |
BBC3 |
BCL2 binding component 3 |
116 |
0.95 |
chr1_173442919_173443120 | 1.09 |
PRDX6 |
peroxiredoxin 6 |
3386 |
0.26 |
chr6_84221670_84222143 | 1.09 |
PRSS35 |
protease, serine, 35 |
288 |
0.94 |
chr3_11551023_11551396 | 1.09 |
VGLL4 |
vestigial like 4 (Drosophila) |
59189 |
0.14 |
chr5_128796390_128797012 | 1.09 |
ADAMTS19-AS1 |
ADAMTS19 antisense RNA 1 |
319 |
0.77 |
chrX_114467670_114468385 | 1.08 |
LRCH2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
601 |
0.77 |
chr9_109622995_109623671 | 1.08 |
ZNF462 |
zinc finger protein 462 |
2045 |
0.37 |
chr2_168049204_168049468 | 1.08 |
XIRP2 |
xin actin-binding repeat containing 2 |
5543 |
0.31 |
chr9_118918144_118918295 | 1.08 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
2136 |
0.4 |
chr13_110960499_110960922 | 1.08 |
COL4A2 |
collagen, type IV, alpha 2 |
1096 |
0.42 |
chr15_73978087_73978288 | 1.08 |
CD276 |
CD276 molecule |
840 |
0.67 |
chr12_47224758_47225230 | 1.07 |
SLC38A4 |
solute carrier family 38, member 4 |
1197 |
0.65 |
chr13_38443188_38443573 | 1.07 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
480 |
0.86 |
chr2_163099691_163099877 | 1.06 |
FAP |
fibroblast activation protein, alpha |
182 |
0.96 |
chr1_75138923_75139762 | 1.06 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr2_183901778_183902686 | 1.05 |
NCKAP1 |
NCK-associated protein 1 |
968 |
0.52 |
chr2_216299376_216299642 | 1.05 |
FN1 |
fibronectin 1 |
1281 |
0.4 |
chr3_158486598_158486991 | 1.05 |
RP11-379F4.8 |
|
13542 |
0.14 |
chr6_72129322_72130506 | 1.05 |
ENSG00000207827 |
. |
16590 |
0.22 |
chr21_30580723_30581000 | 1.05 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
14393 |
0.13 |
chr19_13137554_13137705 | 1.04 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1818 |
0.2 |
chr18_57488899_57489050 | 1.04 |
ENSG00000221471 |
. |
72065 |
0.1 |
chr3_149792357_149792570 | 1.04 |
ENSG00000243321 |
. |
3155 |
0.25 |
chr3_114225635_114225979 | 1.04 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
52143 |
0.16 |
chr6_129455122_129455296 | 1.04 |
LAMA2 |
laminin, alpha 2 |
250867 |
0.02 |
chr13_31444003_31444208 | 1.04 |
MEDAG |
mesenteric estrogen-dependent adipogenesis |
36223 |
0.17 |
chr2_160918347_160919586 | 1.03 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr17_46646430_46646725 | 1.03 |
HOXB3 |
homeobox B3 |
4808 |
0.08 |
chr4_157891142_157892336 | 1.03 |
PDGFC |
platelet derived growth factor C |
316 |
0.91 |
chr8_495850_496251 | 1.03 |
TDRP |
testis development related protein |
269 |
0.95 |
chr9_118359454_118359605 | 1.03 |
DEC1 |
deleted in esophageal cancer 1 |
455432 |
0.01 |
chr5_58571069_58571855 | 1.03 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
483 |
0.9 |
chr2_163099011_163099583 | 1.03 |
FAP |
fibroblast activation protein, alpha |
261 |
0.94 |
chrX_100475310_100475812 | 1.02 |
DRP2 |
dystrophin related protein 2 |
628 |
0.73 |
chr7_93551338_93552000 | 1.02 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
658 |
0.67 |
chr11_121969590_121969741 | 1.02 |
ENSG00000207971 |
. |
887 |
0.47 |
chr4_122077287_122077641 | 1.01 |
TNIP3 |
TNFAIP3 interacting protein 3 |
8031 |
0.23 |
chr17_31255277_31255844 | 1.01 |
TMEM98 |
transmembrane protein 98 |
332 |
0.89 |
chr11_8740394_8740932 | 1.01 |
ST5 |
suppression of tumorigenicity 5 |
27 |
0.96 |
chr3_29554516_29555025 | 1.01 |
RBMS3-AS2 |
RBMS3 antisense RNA 2 |
103776 |
0.08 |
chr2_179728284_179728567 | 1.01 |
CCDC141 |
coiled-coil domain containing 141 |
21253 |
0.16 |
chr13_38172411_38172686 | 1.01 |
POSTN |
periostin, osteoblast specific factor |
315 |
0.95 |
chr8_116675050_116675578 | 1.01 |
TRPS1 |
trichorhinophalangeal syndrome I |
1409 |
0.6 |
chr4_138045655_138046009 | 1.01 |
ENSG00000222526 |
. |
103450 |
0.09 |
chr9_79520622_79521003 | 1.01 |
PRUNE2 |
prune homolog 2 (Drosophila) |
189 |
0.97 |
chr1_32168571_32169014 | 1.00 |
COL16A1 |
collagen, type XVI, alpha 1 |
976 |
0.48 |
chr21_17960305_17960805 | 1.00 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr9_111206334_111206588 | 1.00 |
ENSG00000222512 |
. |
85252 |
0.11 |
chr5_15499822_15500142 | 1.00 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
323 |
0.94 |
chr10_35102956_35103650 | 1.00 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr5_72741608_72741807 | 0.99 |
FOXD1 |
forkhead box D1 |
2645 |
0.29 |
chr7_94024612_94024816 | 0.99 |
COL1A2 |
collagen, type I, alpha 2 |
841 |
0.73 |
chr8_49293521_49293747 | 0.98 |
ENSG00000252710 |
. |
73044 |
0.13 |
chr13_103054295_103054752 | 0.98 |
FGF14 |
fibroblast growth factor 14 |
399 |
0.89 |
chr2_151339877_151340148 | 0.97 |
RND3 |
Rho family GTPase 3 |
1884 |
0.52 |
chr4_102121638_102121810 | 0.97 |
ENSG00000221265 |
. |
129847 |
0.05 |
chr5_95068939_95069254 | 0.97 |
CTD-2154I11.2 |
|
1097 |
0.44 |
chr4_187476084_187476468 | 0.96 |
RP11-215A19.2 |
|
188 |
0.76 |
chr2_213403391_213403972 | 0.96 |
ERBB4 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
116 |
0.98 |
chr4_144303651_144303881 | 0.96 |
GAB1 |
GRB2-associated binding protein 1 |
668 |
0.76 |
chr7_20372921_20373226 | 0.95 |
CTA-293F17.1 |
|
1703 |
0.35 |
chr1_81703498_81704139 | 0.95 |
ENSG00000223026 |
. |
13656 |
0.28 |
chr14_66760490_66760793 | 0.95 |
ENSG00000200860 |
. |
116288 |
0.07 |
chr5_97790939_97791149 | 0.95 |
ENSG00000223053 |
. |
183891 |
0.03 |
chr10_33630004_33630255 | 0.95 |
NRP1 |
neuropilin 1 |
4939 |
0.3 |
chr1_57041430_57041821 | 0.94 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
3616 |
0.34 |
chr3_99592520_99592733 | 0.94 |
FILIP1L |
filamin A interacting protein 1-like |
2322 |
0.38 |
chr12_78482191_78482621 | 0.94 |
RP11-136F16.1 |
|
3111 |
0.35 |
chr1_66258526_66259233 | 0.94 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
15 |
0.99 |
chr7_17720120_17720505 | 0.94 |
SNX13 |
sorting nexin 13 |
259779 |
0.02 |
chr2_5833762_5834449 | 0.94 |
SOX11 |
SRY (sex determining region Y)-box 11 |
1306 |
0.4 |
chr10_33580419_33580715 | 0.93 |
ENSG00000244356 |
. |
3038 |
0.32 |
chr7_115912354_115912783 | 0.93 |
TES |
testis derived transcript (3 LIM domains) |
22079 |
0.19 |
chr4_81192022_81192173 | 0.93 |
FGF5 |
fibroblast growth factor 5 |
4304 |
0.29 |
chr3_79432526_79432918 | 0.93 |
ENSG00000265193 |
. |
124315 |
0.06 |
chr3_64252728_64253099 | 0.93 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
742 |
0.75 |
chr18_66465448_66465631 | 0.93 |
CCDC102B |
coiled-coil domain containing 102B |
113 |
0.97 |
chr12_13351879_13352395 | 0.92 |
EMP1 |
epithelial membrane protein 1 |
2417 |
0.37 |
chr9_97770438_97770821 | 0.92 |
C9orf3 |
chromosome 9 open reading frame 3 |
3351 |
0.26 |
chr21_36209765_36209982 | 0.92 |
RUNX1 |
runt-related transcription factor 1 |
49607 |
0.17 |
chr4_55095719_55096018 | 0.91 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
142 |
0.98 |
chr2_145780897_145781240 | 0.91 |
ENSG00000253036 |
. |
311570 |
0.01 |
chr7_70159815_70160908 | 0.91 |
AUTS2 |
autism susceptibility candidate 2 |
33764 |
0.25 |
chr2_44625134_44625326 | 0.91 |
CAMKMT |
calmodulin-lysine N-methyltransferase |
25349 |
0.2 |
chr12_15952055_15952226 | 0.91 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
9630 |
0.27 |
chr1_214722280_214722431 | 0.91 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
2211 |
0.42 |
chr13_24121492_24121736 | 0.91 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
22895 |
0.25 |
chr1_153957648_153957888 | 0.91 |
RAB13 |
RAB13, member RAS oncogene family |
1060 |
0.29 |
chr7_19145980_19146451 | 0.90 |
AC003986.6 |
|
5882 |
0.17 |
chr19_41725215_41725482 | 0.90 |
AXL |
AXL receptor tyrosine kinase |
208 |
0.89 |
chr2_66666437_66666864 | 0.90 |
MEIS1 |
Meis homeobox 1 |
197 |
0.85 |
chr2_158030573_158030769 | 0.90 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
83439 |
0.1 |
chr2_119603311_119603908 | 0.90 |
EN1 |
engrailed homeobox 1 |
1645 |
0.51 |
chr3_141928917_141929107 | 0.89 |
GK5 |
glycerol kinase 5 (putative) |
15416 |
0.22 |
chr14_45433529_45433743 | 0.89 |
FAM179B |
family with sequence similarity 179, member B |
2194 |
0.25 |
chr4_148402515_148403207 | 0.89 |
EDNRA |
endothelin receptor type A |
777 |
0.76 |
chr14_63671002_63671585 | 0.89 |
RHOJ |
ras homolog family member J |
167 |
0.97 |
chr13_22190759_22190945 | 0.89 |
MICU2 |
mitochondrial calcium uptake 2 |
12499 |
0.22 |
chr4_111507244_111507551 | 0.89 |
PITX2 |
paired-like homeodomain 2 |
36810 |
0.19 |
chr11_68038557_68038708 | 0.89 |
C11orf24 |
chromosome 11 open reading frame 24 |
783 |
0.67 |
chr18_9416679_9416911 | 0.88 |
RALBP1 |
ralA binding protein 1 |
58212 |
0.1 |
chr9_13278507_13279169 | 0.88 |
RP11-272P10.2 |
|
348 |
0.67 |
chr2_206547405_206548278 | 0.88 |
NRP2 |
neuropilin 2 |
143 |
0.98 |
chr7_13985663_13985986 | 0.88 |
ETV1 |
ets variant 1 |
40242 |
0.2 |
chr1_225117686_225118141 | 0.88 |
DNAH14 |
dynein, axonemal, heavy chain 14 |
529 |
0.87 |
chr12_46949518_46949939 | 0.88 |
SLC38A2 |
solute carrier family 38, member 2 |
183078 |
0.03 |
chr11_12696722_12697409 | 0.88 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
15 |
0.99 |
chr10_128593931_128594173 | 0.88 |
DOCK1 |
dedicator of cytokinesis 1 |
74 |
0.98 |
chr8_77867156_77867509 | 0.88 |
ENSG00000266712 |
. |
11754 |
0.26 |
chr6_17986477_17986974 | 0.88 |
KIF13A |
kinesin family member 13A |
969 |
0.69 |
chr10_62331958_62332443 | 0.88 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
221 |
0.97 |
chr1_39572596_39572941 | 0.87 |
MACF1 |
microtubule-actin crosslinking factor 1 |
1685 |
0.35 |
chr12_54653033_54653889 | 0.87 |
CBX5 |
chromobox homolog 5 |
85 |
0.93 |
chr1_156098075_156098411 | 0.87 |
LMNA |
lamin A/C |
1649 |
0.24 |
chrX_34673939_34674563 | 0.87 |
TMEM47 |
transmembrane protein 47 |
1154 |
0.68 |
chr2_131010330_131010897 | 0.87 |
TUBA3E |
tubulin, alpha 3e |
54579 |
0.08 |
chr5_126626527_126627025 | 0.87 |
MEGF10 |
multiple EGF-like-domains 10 |
225 |
0.95 |
chr18_61646573_61646730 | 0.87 |
SERPINB8 |
serpin peptidase inhibitor, clade B (ovalbumin), member 8 |
391 |
0.86 |
chr12_76422291_76422442 | 0.86 |
RP11-290L1.3 |
|
1908 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.0 | 2.9 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 3.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 2.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 3.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 2.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.7 | 2.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 2.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.7 | 2.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.7 | 2.7 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.6 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 1.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.5 | 3.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 2.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 2.0 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.5 | 1.4 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.5 | 1.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.3 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.4 | 1.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.4 | 2.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.4 | 0.9 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 1.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 1.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 9.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 0.8 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.4 | 1.5 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.4 | 1.9 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.4 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 2.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.3 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.3 | 0.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.9 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.3 | 2.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 0.9 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.3 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.9 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 2.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.1 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.3 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.3 | 0.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.5 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.3 | 1.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 1.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.5 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.3 | 1.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 3.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 0.3 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.3 | 3.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 2.3 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.3 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 1.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.3 | 1.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 2.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.7 | GO:0051940 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 1.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 1.0 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.9 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 2.8 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 2.8 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 2.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.6 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.4 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 0.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 3.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 1.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.2 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.2 | 0.9 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.7 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 1.8 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.2 | 0.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.3 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.2 | 2.9 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 1.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.5 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.3 | GO:0021754 | facial nucleus development(GO:0021754) |
0.2 | 0.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 3.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.9 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 1.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.4 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.4 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 2.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.8 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 1.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.9 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 4.4 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.5 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.6 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 1.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 11.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.8 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.2 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 1.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 1.8 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.1 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.1 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.1 | 0.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 2.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.5 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.6 | GO:0019098 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.1 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:2000573 | positive regulation of telomerase activity(GO:0051973) positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.1 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.5 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 2.3 | GO:0044344 | fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.2 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.2 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.0 | GO:0098773 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.0 | 0.6 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.2 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.1 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0007431 | salivary gland development(GO:0007431) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.4 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.0 | 0.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.3 | GO:0071451 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 2.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 1.5 | GO:0030509 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0021536 | diencephalon development(GO:0021536) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.2 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.2 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.3 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.4 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.5 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0014032 | neural crest cell development(GO:0014032) neural crest cell differentiation(GO:0014033) |
0.0 | 0.1 | GO:1901983 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.2 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.6 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.4 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.2 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 1.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0003279 | cardiac septum development(GO:0003279) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.0 | GO:0010594 | regulation of endothelial cell migration(GO:0010594) |
0.0 | 0.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.8 | 9.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 2.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.7 | 4.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.7 | 3.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 2.7 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 2.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.7 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.7 | GO:0043656 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.2 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.6 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 4.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 2.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.6 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.9 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 2.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 6.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 26.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.9 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 4.5 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 5.9 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 6.5 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 4.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 3.7 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 1.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 4.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 2.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 10.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 1.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 20.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 2.2 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.2 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.7 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 1.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 4.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 4.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 4.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 2.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.4 | 2.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 5.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 3.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 1.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 1.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 1.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.0 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 3.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 3.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 16.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 2.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 2.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 2.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.5 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 2.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 5.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.9 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 1.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 7.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 3.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 17.6 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 3.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 4.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 2.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 1.7 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 6.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 17.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 5.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 5.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 26.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 14.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 15.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 1.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 11.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 20.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 0.3 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.3 | 2.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 6.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 2.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 3.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |